Bioequivalence and Bioavailability Forum 20:36 CEST

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Oral Dispersible Tablet BE study USFDA submission [Regulatives / Guidelines]

posted by jag009 - NJ, 2018-04-13 21:23  - Posting: # 18680
Views: 836

Hi,

» Till now , FDA has not issued the general invivo BE study recommendation to conduct the ODT

I did a bunch of them a few years back but ours were NDAs (505b2s, ODTs vs reg tablets). Tablet on tongue, subject can't chew but can "suck" (you know, the small movement of your tongue like when you swallow something) on the tablet. After 10 or 30 seconds (don't remember details) check mouth. Once everything is disappear, then we give water...

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,782 posts in 4,002 threads, 1,256 registered users;
online 12 (0 registered, 12 guests [including 11 identified bots]).

[…] our greatest mistake would be to forget that data
is used for serious decisions in the very real world,
and bad information causes suffering and death.    Ben Goldacre

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed